Tokyo, Japan

Toju Hata


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Tokyo, JA (1976)
  • Tokyo, JP (1980 - 1982)

Company Filing History:


Years Active: 1976-1982

Loading Chart...
6 patents (USPTO):

Title: Toju Hata: Innovator in Medicinal Chemistry

Introduction

Toju Hata is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 6 patents to his name, Hata's work has the potential to impact the treatment of infectious diseases.

Latest Patents

Hata's latest patents include innovative compounds such as nanaomycin A and its derivatives. The first patent describes a new compound represented by a specific general formula, where R is H and R' is OH, identifying it as nanaomycin A. The second patent introduces nanaomycin B, a quinone-type compound that exhibits activity against mycoplasma, Gram-positive bacteria, and trichophyton. This compound is particularly useful as a medicament for infectious diseases caused by these pathogens. The acute toxicity of nanaomycin B, measured by the LD50 in mice, is 169 mg/Kg. The production of nanaomycin B involves fermentation using a strain of Streptomyces cultured under aerobic conditions.

Career Highlights

Throughout his career, Toju Hata has worked at esteemed institutions, including the Kitasato Institute. His research has focused on developing compounds that can effectively combat various infectious diseases, showcasing his dedication to advancing medical science.

Collaborations

Hata has collaborated with notable colleagues such as Juichi Awaya and Satoshi Omura. These partnerships have likely contributed to the success of his research and the development of his patented compounds.

Conclusion

Toju Hata's innovative work in medicinal chemistry, particularly with nanaomycin compounds, highlights his significant contributions to the field. His patents reflect a commitment to addressing critical health challenges through scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…